Search

for
Search:

Did you mean Sustained Release?

GlossarySustained Release

drug delivery system releasing medication slowly over time

Sustained Release (SR), also known as Extended Release (ER) or Controlled Release (CR), refers to a drug delivery system designed to release a medication slowly over time. This allows for a more consistent therapeutic effect, reduces the frequency of dosing, and can improve patient compliance by maintaining steadier drug levels in the bloodstream.

Related Terms

Research

5 / 1000+ results

An Injectable Ibuprofen Sustained-Release Composite Hydrogel System Effectively Accelerates Diabetic Wound Healing Via Anti-Inflammatory Effects And Angiogenesis

research An Injectable Ibuprofen Sustained-Release Composite Hydrogel System Effectively Accelerates Diabetic Wound Healing via Anti-Inflammatory Effects and Angiogenesis

9 citations , April 2025 in “International Journal of Nanomedicine”

An injectable ibuprofen gel speeds up diabetic wound healing by reducing inflammation and promoting tissue growth.

research Microencapsulation of Poorly Water-soluble Finasteride in Polyvinyl Alcohol/chitosan Microspheres as a Long-term Sustained Release System for Potential Embolization Applications

11 citations , January 2020 in “Engineered science”

Sustained Exosome-Guided Macrophage Polarization Using Hydrolytically Degradable PEG Hydrogels for Cutaneous Wound Healing: Identification of Key Proteins and miRNAs, and Sustained Release Formulation

research Sustained Exosome‐Guided Macrophage Polarization Using Hydrolytically Degradable PEG Hydrogels for Cutaneous Wound Healing: Identification of Key Proteins and MiRNAs, and Sustained Release Formulation

40 citations , March 2022 in “Small”

Hydrogel with M2-derived exosomes improves wound healing by slowly releasing exosomes that help reduce inflammation and promote tissue repair.

research Development of Novel Drug Delivery Systems for the Treatment of Alopecia

July 2026 in “International Journal of Drug Delivery Technology”

New drug delivery systems show promise for better alopecia treatment but need more safety tests and standardization.

Development and Evaluation of a Niosome-Integrated Microneedle System for Targeted Follicular Delivery of Ketoconazole in Alopecia Therapy

research Development and Evaluation of a Niosome-Integrated Microneedle System for Targeted Follicular Delivery of Ketoconazole in Alopecia Therapy

April 2026 in “BioNanoScience”

A new microneedle system may improve hair loss treatment by delivering ketoconazole directly to hair follicles.

View more "sustained release systems" in research →

Community Join

5 / 198 results

community Breezula Phase III 12-Month Data Released by Cosmo Pharma

in Research/Science 43 upvotes 3 months ago

Clascoterone 5% topical solution is effective and safe for long-term use in treating male pattern hair loss. Cosmo Pharma aims for EU and US approval, with a potential US release in late 2027 or early 2028.

community Does Finasteride Sustain Minoxidil-grown Hairs?

in Finasteride/Dutasteride 8 upvotes 2 years ago

The post discusses whether finasteride can maintain hair growth stimulated by minoxidil. The response indicates that finasteride cannot sustain minoxidil-grown hairs.

community PP405 Won't Work Long Term: Hair Follicle Damage Due to Abuse of the ISR System

in Research/Science 64 upvotes 10 months ago

PP405 may damage hair follicles if used long-term, suggesting cycling might be necessary. Combining it with finasteride could help maintain hair growth.

community People are hyped about PP405 but what about Veradermics phase 2!

in Research/Science 39 upvotes 9 months ago

Veradermics' phase 2 trial of slow-release oral minoxidil shows promising hair regrowth with minimized side effects, gaining significant attention and funding. PP405 is also noted for its potential as a side-effect-free alternative.

community The New, Improved CB-03-01/Setipiprant Group Buy

26 upvotes 9 years ago

The group buy for CB-03-01, a topical anti-androgen for hair loss, was postponed and refunded due to issues with the product's form and solubility. The product, also known as Breezula, is an alternative to finasteride with fewer side effects, but its official release is delayed until 2021.

View more "sustained release systems" in community →

Learn

2 / 801 results

learn Stem Cell Factor

learn Osteopontin

signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

View more "sustained release systems" in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →